A model for susceptibility polymorphisms for complex diseases: Apolipoprotein E and Alzheimer disease

Neurogenetics

Volumn 1, Issue 1, 1997, Pages 3-11

  Roses, Allen D ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Diagnosis; Epidemiology; Ethics; Genetic; Prediction; Preventive therapy; Risk factors

Indexed keywords

APOLIPOPROTEIN E;

AGE; ALZHEIMER DISEASE; BIOLOGICAL MODEL; BREAST TUMOR; CHROMOSOME MAP; GENETIC POLYMORPHISM; GENETIC PREDISPOSITION; GENETICS; HUMAN; MUTATION; PSYCHOLOGICAL ASPECT; REVIEW; RISK FACTOR;

AGE FACTORS; ALZHEIMER DISEASE; APOLIPOPROTEINS E; BREAST NEOPLASMS; CHROMOSOME MAPPING; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MODELS, GENETIC; MUTATION; POLYMORPHISM, GENETIC; RISK FACTORS;

EID: 0031128778     PISSN: 13646745     EISSN: None     Source Type: Journal    
DOI: 10.1007/s100480050001     Document Type: Review

References (82)

1. Mohr, J. (1954) A study of linkage in man. Copenhagen: Munksgaard.
2. Gusella, J.F., Wexler, N.S., Conneally, P.M., et al. (1983) A polymorphic DNA marker genetically linked to Huntington's disease. Nature, 306, 234-238.
3. Monaco, A.P., Bertelson, C.J., Middlesworth, W., et al. (1985) Detection of deletions spanning the Duchenne muscular dystrophy locus using a tightly linked DNA segment. Nature, 316, 842-845.
4. Monaco, A.P., Neve, R.L., Colletti-Feener, C., Bertelson, C.J., Kurnit, D.M., Kunkel, L.M. (1986) Isolation of candidate cDNAs for portions of the Duchenne muscular dystrophy gene. Nature, 323, 646-650.
5. Riordan, J.R., Rommens, J.M., Kerem, B., et al. (1989) Identification of the cystic fibrosis gene: cloning and characterization of complementary DNA. Science, 245, 1066-1073.
6. Editorial (1996) To Affinity ... and Beyond. Nature Genet., 14, 367-370.
7. Goate, A., Chartier-Harlin, M.C., Mullan, M., et al. (1991) Segregation of a missense mutation in the amyloid precursor protein gene with familial Alzheimer's disease. Nature, 349, 704-706.
8. Strittmatter, W.J., Saunders, A.M., Schmechel, D., et al. (1993) Apolipoprotein E: high-avidity binding to beta-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease. Proc. Natl. Acad. Sci. USA, 90, 1977-1981.
9. Saunders, A.M., Strittmatter, W.J., Schmechel, D., et al. (1993) Association of apolipoprotein E allele epsilon 4 with late-onset familial and sporadic Alzheimer's disease. Neurology, 43, 1467-1472.
10. Corder, E.H., Saunders, A.M., Strittmatter, W.J., et al. (1993) Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. Science, 261, 921-923.
11. Corder, E.H., Saunders, A.M., Risch, N.J., et al. (1994) Protective effect of apolipoprotein E type 2 allele for late onset Alzheimer disease. Nature Genet., 7, 180-184.
12. Roses, A.D. (1996) Apolipoprotein E alleles as risk factors in Alzheimer disease. Annu. Rev. Med., 47, 387-400.
13. Roses, A.D. (1997) Apolipoprotein E and Alzheimer's disease. In: Rosenberg, R.N., Prusiner, S.B., DiMauro, S., Barchi, R.L., eds. The molecular and genetic basis of neurological disease. 2nd ed. Stoneham, MA: Butterworth-Heinemann pp. 1019-1036.
14. Lander, E.S., Schork, N.J. (1994) Genetic dissection of complex traits. Science, 265, 2037-2048.
15. Lewis, C.M., Neuhausen, S.L., Daley, D., et al. (1996) Genetic heterogeneity and unmapped genes for colorectal cancer. Cancer Res., 56, 1382-1388.
16. Richards, R.I., Sutherland, G.R. (1992) Heritable unstable DNA sequences [news]. Nature Genet., 1, 7-9.
17. Gusella, J.F., MacDonald, M.E. (1996) Trinucleotide instability: a repeating theme in human inherited disorders. Annu. Rev. Med., 47, 201-209.
18. Monckton, D.G., Wong, L.J., Ashizawa, T., Caskey, C.T. (1995) Somatic mosaicism, germline expansions, germline reversions and intergenerational reductions in myotonic dystrophy males: small pool PCR analyses. Hum. Mol. Genet., 4, 1-8.
19. La Spada, A.R., Wilson, E.M., Lubahn, D.B., Harding, A.E., Fischbeck, K.H. (1991) Androgen receptor gene mutations in X-linked spinal and bulbar muscular atrophy. Nature, 352, 77-79.
20. The Huntington's Disease Collaborative Research Group. (1993) A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes. Cell, 72, 971-983.
21. Koide, R., Ikeuchi, T., Onodera, O., et al. (1994) Unstable expansion of CAG repeat in hereditary dentatorubral-pallidoluysian atrophy (DRPLA). Nature Genet., 6, 9-13.
22. Nagafuchi, S., Yanagisawa, H., Sato, K., et al. (1994) Dentatorubral and pallidoluysian atrophy expansion of an unstable CAG trinucleotide on chromosome 12p. Nature Genet., 6, 14-18.
23. Orr, H.T., Chung, M.Y., Banfi, S., et al. (1993) Expansion of an unstable trinucleotide CAG repeat in spinocerebellar ataxia type 1. Nature Genet., 4, 221-226.
24. Imbert, G., Saudou, F., Yvert, G., et al. (1996) Cloning of the gene for spinocerebellar ataxia 2 reveals a locus with high sensitivity to expanded CAG/glutamine repeats. Nature Genet. 14, 285-291.
25. Sanpei, K., Takano, H., Igarashi, S., et al. (1996) Identification of the spinocerebellar ataxia type 2 gene using a direct identification of repeat expansion and cloning technique. Nature Genet., 14, 277-284.
26. Pulst, S.M., Nechiporuk, A., Nechiporuk, T., et al. (1996) Moderate expansion of a normally biallelic trinucleotide repeat in spinocerebellar ataxia type 2. Nature Genet., 14, 269-276.
27. Zuchenko, O., Bailey, J., Bonnen, P., et al. (1997) Autosomal dominant cerebellar ataxia (SCA6) associated with small polyglutamine expansions in the alpha 1A-voltage-dependent calcium channel. Nature Genet., 15, 62-69.
28. Burke, J.R., Enghild, J.J., Martin, M.E., et al. (1996) Huntington and DRPLA proteins selectively interact with the enzyme GAPDH. Nature Med. 2, 347-350.
29. Richards, R.R., Roses, A.D. (1997) Do repetitive sequences have a role in the evolution and development of the human brain? Lancet, submitted.
30. Roses, A.D. (1996) From genes to mechanisms to therapies - lessons to be learned from neurological disorders. Nature Med. 2, 267-269.
31. Friend, S.H. (1996) Breast cancer susceptibility testing - realities in the post-genomic era. Nature Genet., 13, 16-17.
32. Cannon-Albright, L.A., Skolnick, M.H. (1996) The genetics of familial breast cancer. Semin. Oncol. 23(Suppl 2), 1-5.
33. Phelan, C.M., Lancaster, J.M., Tonin, P., et al. (1996) Mutation analysis of the BRCA2 gene in 49 site-specific breast cancer families. Nature Genet. 13, 120-122.
34. Teng, D.H., Bogden, R., Mitchell, J., et al. (1996) Low incidence of BRCA2 mutations in breast carcinoma and other cancers. Nature Genet., 13, 241-244.
35. Hacia, J.G., Brody, L.C., Chee, M.S., Fodor, S.P.A., Collins, F.S. (1996) Detection of heterozygous mutations in BRCA1 using high density oligonucleotide arrays and two-colour fluorescence analysis. Nature Genet., 14, 441-447.
36. Harding, A.E. (1992) Molecular genetics and clinical aspects of inherited disorders of nerve and muscle. Curr. Opin. Neurol. Neurosurg., 5, 600-604.
37. Rosenberg, R. (1995) The genetic basis of ataxia. Clin. Neurosci., 3, 1-4.
38. Roses, A.D. (1995) Perspective: On the metabolism of apolipoprotein E and the Alzheimer diseases. Exp. Neurol., 132, 149-156.
39. Xu, P.-T., Schmechel, D., Rothrock-Christian, T., et al. (1996) Human apolipoprotein E2, E3 and E4 isoform-specific transgenic mice: human-like pattern of neuronal immunoreactivity in central nervous system not observed in wild type mice. Neurobiol Dis. in press.
40. Roses, A.D. (1997) A new paradigm for clinical dementia evaluations: Alzheimer disease and apolipoprotein E genotypes. In: Post SG, Whitehouse PJ, eds. Ethics, Genetics and Alzheimer Disease. Baltimore: Johns Hopkins University Press, in press.
41. Roses, A.D., Pericak, V.M., Saunders, A.M., Schmechel, D., Goldgaber, D., Strittmatter, W. (1994) Complex genetic disease: can genetic strategies in Alzheimer's disease and new genetic mechanisms be applied to epilepsy? Epilepsia 35, S20-S28.
42. Lannfelt, L., Lilius, L., Nastase, M., et al. (1994) Lack of association between apolipoprotein E allele epsilon 4 and sporadic Alzheimer's disease. Neurosci. Lett., 169, 175-178.
43. Basun, H., Grut, M., Winblad, B., Lannfelt, L. (1995) Apolipoprotein epsilon 4 allele and disease progression in patients with late-onset Alzheimer's disease. Neurosci. Lett. 183, 32-34.
44. Maestre, G., Ottman, R., Stern, Y., et al. (1995) Apolipoprotein E and Alzheimer's disease: ethnic variation in genotypic risks. Ann. Neurol., 37, 254-259.
45. Hendrie, H.C., Hall, K.S., Hui, S., et al. (1995) Apolipoprotein E genotypes and Alzheimer's disease in a community study of elderly African Americans. Ann. Neurol., 37, 118-120.
46. Kamboh, M.I. (1995) Apolipoprotein E polymorphism and susceptibility to Alzheimer's disease. Hum. Biol., 67, 195-215.
47. Namba, Y., Tomonaga, M., Kawasaki, H., Otomo, E., Ikeda, K. (1991) Apolipoprotein E immunoreactivity in cerebral amyloid deposits and neurofibrillary tangles in Alzheimer's disease and kuru plaque amyloid in Creutzfeldt-Jakob disease. Brain Res., 541, 163-166.
48. Schmechel, D.E., Saunders, A.M., Strittmatter, W.J., et al. (1993) Increased amyloid beta-peptide deposition in cerebral cortex as a consequence of apolipoprotein E genotype in late-onset Alzheimer disease. Proc. Natl. Acad. Sci. USA, 90, 9649-9653.
49. Gomez-Isla, T., West, H.L., Rebeck, G.W., et al. (1996) Clinical and pathological correlates of apolipoprotein E epsilon 4 in Alzheimer's disease. Ann. Neurol., 39, 62-70.
50. Strittmatter, W.J., Weisgraber, K.H., Goedert, M., et al. (1994) Hypothesis: microtubule instability and paired helical filament formation in the Alzheimer disease brain are related to apolipoprotein E genotype. Exp. Neurol., 125, 163-171.
51. Horsburgh, K., Nicoll, J.A.R. (1996) Selective alterations in the cellular distribution of apolipoprotein E immunoreactivity following transient cerebral ischaemia. Neuropathol. Appl. Neurobiol., 22, 342-349.
52. Selkoe, D.J. (1994) Alzheimer's disease: a central role for amyloid. J. Neuropathol. Exp. Neurol. 53, 438-447.
53. Roses, A.D. (1994) Apolipoprotein E affects the rate of Alzheimer disease expression: beta-amyloid burden is a secondary consequence dependent on APOE genotype and duration of disease. J. Neuropathol. Exp. Neurol., 53, 429-437.
54. Schellenberg, G.D. (1995) Genetic dissection of Alzheimer disease, a heterogeneous disorder. Proc. Natl. Acad. Sci. USA, 92, 8552-8559.
55. Roses, A.D, Devlin, B., Conneally, P.M., et al. (1995) Measuring the genetic contribution of APOE in late-onset Alzheimer disease. Am. J. Hum. Genet. 57, A202.
56. Haines, J.L., Ter-Minassian, M., Bazyk, A., et al. (1996) A complete genomic screen for multiple sclerosis underscores a role for the major histocompatability complex. The Multiple Sclerosis Genetics Group. Nature Genet., 13, 469-471.
57. Ebers, G.C., Kukay, K., Bulman, D.E., et al. (1996) A full genome search in multiple sclerosis. Nature Genet. 13, 472-476.
58. Sawcer, S., Jones, H.B., Feakes, R., et al. (1996) A genome screen in multiple sclerosis reveals susceptibility loci on chromosome 6p21 and 17q22. Nature Genet., 13, 464-468.
59. Kuokkanen, S., Sundvall, M., Terwilliger, J.D., et al. (1996) A putative vulnerability locus to multiple sclerosis maps to 5p14-p12 in a region syntenic to the murine locus EAE2. Nature Genet., 13, 477-480.
60. Martin, J.B. (1993) Molecular genetics in neurology. Ann. Neurol., 34, 757-773.
61. Saunders, A.M., Hulette, C., Welsh, K.A., et al. (1996) Specificity, sensitivity and predictive value of apolipoprotein E genotyping forsporadic Alzheimer disease. Lancet, 348, 90-93.
62. Welsh-Bohmer, K.A., Gearing, M., Saunders, A.M., Roses, A.D., Mirra, S. (1996) Apolipoprotein E genotypes in a neuropathological series from the Consortium to Establish a Registry for Alzheimer's disease (CERAD). Ann. Neurol., submitted for publication.
63. Kakulas, B.A., Wilton, S.D., Fabian, V.A., Jones, T.M. (1996) Apolipoprotein-E genotyping in the diagnosis of Alzheimer's disease in an autopsy confirmed series. Lancet, 348, 483.
64. Relkin, N.R., Tanzi, R., Breitner, J., et al. (1996) Apolipoprotein E genotyping in Alzheimer's disease. Lancet, 347, 1091-1095.
65. Roses, A.D. (1996) Apolipoprotein E Genotype: Utility in clinical practice in Alzheimer's disease. J. Am. Geront. Soc., 44, 1-3.
66. Roses, A.D., Saunders, A.M. (1997) Apolipoprotein E genotyping as a diagnostic adjunct for Alzheimer disease. Internat. Psychogeriat., in press.
67. Schachter, F., Faure, D.L., Guenot, F., et al. (1994) Genetic associations with human longevity at the APOE and ACE loci. Nature Genet., 6, 29-32.
68. St George-Hyslop, P., McLachlan, D.C., Tsuda, T., et al. (1994) Alzheimer's disease and possible gene interaction. Science, 263, 537. [published erratum appears in Science (1994), 263, 904].
69. Nacmias, B., Latorraca, S., Piersanti, P., et al. (1995) ApoE genotype and familial Alzheimer's disease: a possible influence on age of onset in APP717 Val→Ile mutated families. Neurosci. Lett., 183, 1-3.
70. Sherrington, R., Rogaev, E.I., Liang, Y., et al. (1995) Cloning of a gene bearing missense mutations in early-onset familial Alzheimer's disease. Nature, 375, 754-760.
71. Rogaev, E., Sherrington, R., Rogaeva, E., et al. (1995) Familial Alzheimer's disease in kindreds with missense mutations in a novel gene on chromosome 1 related to the Alzheimer's disease type 3 gene. Nature, 376, 600-602.
72. Levy-Lehad, E., Wasco, W., Poorkaj, P., et al. (1995) Candidate gene for thé chromosome 1 familial Alzheimer's disease locus. Science, 269, 973-977.
73. Lynch, T., Sano, M., Marder, K.S., et al. (1994) Clinical characteristics of a family with chromosome 17-linked disinhibition-dementia-parkinsonism-amyotrophy complex. Neurology, 44, 1878-1884.
74. Wijker, M., Wszolek, Z.K., Wolters, E.C., et al. (1996) Localization of the gene for rapidly progressive autosomal dominant parkinsonism and dementia with pallido-ponto-nigral degeneration to chromosome 17q21. Hum. Mol. Genet., 5, 151-154.
75. Sima, A.A., Defendini, R., Keohane, C., et al. (1996) The neuropathology of chromosome 17-linked dementia. Ann. Neurol., 39, 734-743.
76. Wilhelmsen, K.C., Lynch, T., Pavlou, E., Higgins, M., Nygaard, T.G. (1994) Localization of disinhibition-dementia-parkinsonism-amyotrophy complex to 17q21-22. Am. J. Hum. Genet. 55, 1159-1165.
77. Yamaoka, L.H., Welsh-Bohmer, K.A., Hulette, C.M., et al. (1996) Linkage of frontotemporal dementia to chromosome 17: clinical and neuropathological characterization of phenotype. Am. J. Hum. Genet., 59, 1306-1312.
78. Haines, J.L., St George-Hyslop, P.H., Rimmler, J.L., et al. (1992) Inheritance of multiple loci in familial Alzheimer disease. Third International Conference on Alzheimer's Disease and Related Disorders 1992, Padova, Italy.
79. Kapp, M.B. (1996) Medicolegal, employment, and insurance issues in APOE genotyping and Alzheimer's disease. In: Relkin, N., Khachaturian, Z., Gandy, S. eds. Apolipoprotein E genotyping in Alzheimer's disease. New York: Ann. N. Y. Acad. Sci., pp. 139-148.
80. Fleck, L.M. (1996) Just caring: the moral and economic costs of APOE genotyping for Alzheimer's disease. In: Relkin, N., Khachaturian, Z., Gandy, S. eds. Apolipoprotein E genotyping in Alzheimer's disease. New York: Ann. N. Y. Acad. Sci. pp. 128-138.
81. Small, G.W., Mazziotta, J.C., Collins, M.T., et al. (1995) Apolipoprotein E type 4 allele and cerebral glucose metabolism in relatives at risk for familial Alzheimer disease. JAMA, 273, 942-947.
82. Reiman, E.M., Caselli, R.J., Yun, L.S., et al. (1996) Preclinical evidence of Alzheimer's disease in persons homozygous for the epsilon 4 allele for apolipoprotein E. N. Engl. J. Med. 334, 752-758.